Offer An Article

Pandemic Latest News

Serum Institute of India

Project NextGen to prepare for future pandemics; The latest health stories from around the world

President Joe Biden’s administration said this week it plans to spend more than $5 billion to stoke development of better coronavirus vaccines and treatments to curb future pandemics. www.science.org/content/article/news-glance-new-us-coronavirus-research-lab-gears-carbon-cost-repurposed-accelerator? Like Operation Warp Speed, its predecessor during the administration of former President Donald Trump, the new program, Project NextGen, will rely on public-private partnerships, The Washington …

Project NextGen to prepare for future pandemics; The latest health stories from around the world Read More »

EU putting weight behind Ethiopia’s Tedros for second WHO DG term

Tedros 2.0? German government sources told Reuters on 23 September that Berlin would officially nominate Tedros as the Director General (DG) of the World Health Organization (WHO) for the second time around and was seeking support from other European Union (EU) member states. At least 17 EU states have said they would also submit his …

EU putting weight behind Ethiopia’s Tedros for second WHO DG term Read More »

Covishield: A single dose may be enough for those previously infected with COVID-19

New research claims that a single dose of Covishield may be sufficient to protect those previously infected with the novel coronavirus which causes COVID-19.  If someone has previously contracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV), researchers at the Assam Medical College and the Indian Council of Medical Research (ICMR) suggest that they may not …

Covishield: A single dose may be enough for those previously infected with COVID-19 Read More »

Patent waivers unlikely to resolve COVID-19 vaccine crisis

Patent waivers for COVID-19 vaccines have been offered up as a suggestion as a means to address the global crisis. While in theory this would allow a shift in production from high-income nations to developing countries, achieving this requires overcoming a significant hurdle – a lack of production capacity. Recently, World Health Organization (WHO) Director-General …

Patent waivers unlikely to resolve COVID-19 vaccine crisis Read More »

Vaccine nationalism, vaccine diplomacy, and India

Ngozi Okonjo-Iweala, who will assume the role of director-general of the World Trade Organization (WTO) next month, has cast a spotlight on vaccine nationalism and warned that progress in combating COVID-19 will be hindered without equitable access to vaccines. Okonjo-Iweala, a Nigerian-American development economist, said “both on a human health basis, as well as an …

Vaccine nationalism, vaccine diplomacy, and India Read More »

Serum Institute of India fire will not hurt vaccine efforts; lives lost

The Serum Institute of India fire is under control. The blaze is not expected to affect COVID-19 vaccine production. The fire broke out at a building under construction at the complex of the world’s largest vaccine manufacturer in Pune, Maharashtra at around 2.45 p.m.. Ten fire tenders responded along with a team from National Disaster …

Serum Institute of India fire will not hurt vaccine efforts; lives lost Read More »

COVID-19 vaccine exports from India in the next few weeks

COVID-19 vaccine exports will commence in the weeks to come, the Government has confirmed. This is despite earlier confusion that the country’s largest vaccine manufacturer was not authorised to do so. India is gearing up for a mass vaccination campaign expected to begin next week. This follows emergency use authorisation for two vaccine candidates: one …

COVID-19 vaccine exports from India in the next few weeks Read More »

Accelerated approval for Pfizer, SII vaccines?

Following the requests by both Pfizer and the Serum Institute of India (SII) for emergency use authorisation for their respective COVID-19 vaccine candidates, the Union Government is considering an accelerated approval process. “We are in the process of reviewing,” said a senior government official quoted by Reuters. “It is an accelerated reviewing process, which is …

Accelerated approval for Pfizer, SII vaccines? Read More »

Emergency use authorisation sought by SII, Pfizer

The Serum Institute of India (SII) is seeking emergency use authorisation for Covishield, also known as the ‘Oxford Vaccine’. Pfizer has done the same for its vaccine candidate. Phase-III trials of Covishield – made by the University of Oxford in collaboration with AstraZeneca – are underway in various parts of the country, conducted by the …

Emergency use authorisation sought by SII, Pfizer Read More »